GO:0001069 regulatory region RNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001069 (regulatory region RNA binding) describes the molecular function of binding to RNA regions that regulate nucleic acid-based processes such as transcription, DNA replication, and DNA repair.
• This activity is mediated by RNA-binding proteins (RBPs) that recognize structured or sequence-specific elements within promoter-associated RNAs, 3' UTR regulatory regions, and other non-coding regulatory transcripts.
• Regulatory region RNA binding is essential for gene expression control, including transcriptional activation, mRNA stability, and translational regulation.
• Dysregulation of regulatory region RNA binding is linked to hematological malignancies, inflammatory diseases, and viral pathogenesis.
• Key experimental approaches include RNA immunoprecipitation, CLIP-seq, and combinatorial classification of RNA-protein binding sites to identify high-confidence regulatory elements.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of regulatory region RNA binding in disease and development.
Description
GO:0001069, regulatory region RNA binding, is a molecular function defined as binding to an RNA region that regulates a nucleic acid-based process, including transcription, DNA replication, and DNA repair. This term captures a critical layer of gene regulation in which proteins recognize specific RNA sequences or structures within regulatory regions to modulate downstream nucleic acid transactions. Unlike general RNA binding, this function is restricted to RNA elements that actively control processes such as promoter activity, replication origin firing, or DNA repair pathway choice. Understanding regulatory region RNA binding is therefore central to decoding how cells orchestrate gene expression and maintain genomic integrity. Researchers study this activity to identify RNA regulatory elements, map RNA-protein interaction networks, and uncover disease mechanisms driven by aberrant RNA-protein complexes. The function has been characterized in diverse contexts, from bacterial quorum-sensing promoters to mammalian cytokine 3' UTRs, highlighting its evolutionary conservation and broad biological significance.
regulatory region RNA binding At A Glance
| GO ID | GO:0001069 |
|---|---|
| GO term | regulatory region RNA binding |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Binding to a RNA region that regulates a nucleic acid-based process. Such processes include transcription, DNA replication, and DNA repair. |
| Major function | Recognition of regulatory RNA elements to control transcription, DNA replication, and DNA repair |
| Related processes | Transcription regulation, mRNA stability, DNA replication, DNA repair |
| Example RNA regions | Promoter-regulatory regions, 3' UTR regulatory elements, viral late RNA regulatory regions |
| Representative proteins | RNA-binding proteins (RBPs), transcription factors with RNA-binding domains, viral transactivators |
What Is GO:0001069?
Regulatory region RNA binding (GO:0001069) is the molecular function of selectively binding to an RNA region that regulates a nucleic acid-based process. Such processes include transcription, DNA replication, and DNA repair. This activity is distinct from general RNA binding because the bound RNA must reside within a regulatory region and directly influence a downstream nucleic acid-based event. The term encompasses binding to promoter-associated RNAs, 3' untranslated region (3' UTR) regulatory elements, and other non-coding regulatory RNAs that control gene expression or genome maintenance.
Why Is regulatory region RNA binding Important in Cell Biology?
Regulatory region RNA binding is important because it provides a direct mechanism for RNA molecules to influence fundamental nucleic acid processes, including transcription, DNA replication, and DNA repair. This function enables cells to integrate RNA signals into gene expression programs and to coordinate responses to developmental and environmental cues. Dysregulation of this activity can lead to uncontrolled gene expression, genomic instability, and disease, as evidenced by its roles in leukemia, inflammatory disorders, and viral infections. Studying regulatory region RNA binding therefore offers insights into basic gene regulation and identifies potential therapeutic targets for a range of human diseases.
• Controls transcription by enabling RNA-binding proteins to recognize promoter-regulatory regions and modulate RNA polymerase activity.
• Regulates mRNA stability and translation through binding to 3' UTR regulatory elements, as shown for TNF-alpha and IL-3.
• Contributes to DNA replication and DNA repair by binding RNA regions that regulate these processes.
• Plays a role in viral pathogenesis, including bovine herpesvirus 4 late RNA and its promoter-regulatory region.
• Is implicated in hematological malignancies, such as IL-3-dependent and autocrine-transformed hematopoietic cells.
• Involved in inflammatory diseases through TNF-alpha mRNA regulatory region binding.
• Provides a basis for identifying high-confidence RNA regulatory elements via combinatorial classification of RNA-protein binding sites.
• Enables biochemical and genomic probing of RNA-protein networks to uncover new regulatory interactions.
• Links transposable elements and G-quadruplex structures to regulatory RNA function.
• Supports the development of CRISPR-based models to dissect causal roles of regulatory region RNA binding in disease.
What Happens During regulatory region RNA binding?
Recognition of regulatory RNA elements
In simple terms: Proteins find and attach to specific RNA regions that control gene activity.
The first step in regulatory region RNA binding is the recognition of a target RNA region by an RNA-binding protein (RBP) or a protein complex. This recognition can be sequence-specific or structure-specific, and it often involves RNA elements within promoter-regulatory regions, 3' UTRs, or other non-coding regulatory transcripts. High-confidence RNA regulatory elements can be identified by combinatorial classification of RNA-protein binding sites, which integrates multiple experimental datasets to distinguish functional binding events from background. For example, the Vibrio fischeri LuxR transcriptional activator domain binds synergistically with RNA polymerase to the lux promoter region, illustrating how protein-RNA interactions at regulatory regions can control transcription.
Formation of RNA-protein complexes
In simple terms: Once bound, proteins and RNA form stable complexes that can carry out regulatory functions.
After initial recognition, regulatory region RNA binding leads to the formation of stable RNA-protein complexes. These complexes can include multiple proteins that assemble on the RNA scaffold to modulate nucleic acid-based processes. In the case of the TNF-alpha 3' UTR, specific RNA-binding proteins form complexes with a novel putative regulatory region, and these complexes are thought to control mRNA stability and translation. Similarly, proteins binding the 3' regulatory region of the IL-3 gene form complexes in IL-3-dependent and autocrine-transformed hematopoietic cells, suggesting a role in cytokine gene regulation.
Modulation of transcription, replication, and repair
In simple terms: The bound RNA-protein complexes then influence processes like transcription, DNA copying, and DNA repair.
The functional outcome of regulatory region RNA binding is the modulation of nucleic acid-based processes, including transcription, DNA replication, and DNA repair. For transcription, binding of regulatory proteins to promoter-associated RNAs can enhance or repress RNA polymerase recruitment and activity. In DNA replication and repair, RNA regions that regulate these processes can be bound by specific RBPs to influence origin firing or repair pathway choice. The exact mechanisms depend on the RNA region and the proteins involved, but the common theme is that the RNA acts as a regulatory platform.
Downstream effects on gene expression and genome stability
In simple terms: These interactions ultimately change which genes are expressed and help maintain genome integrity.
Regulatory region RNA binding ultimately affects gene expression programs and genome stability. For instance, binding to the 3' UTR of TNF-alpha mRNA can alter the stability and translation of this inflammatory cytokine, thereby influencing immune responses. In hematopoietic cells, binding to the IL-3 gene 3' regulatory region may contribute to autocrine transformation and leukemogenesis. Viral regulatory region RNA binding, such as in bovine herpesvirus 4, can control viral late gene expression and pathogenesis. Thus, this molecular function has broad consequences for cellular physiology and disease.
Key Genes Involved in GO:0001069 regulatory region RNA binding
The following genes and proteins are representative of regulatory region RNA binding activity, based on published literature and their roles in recognizing regulatory RNA elements.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LuxR | Transcriptional activator that binds the lux promoter region in Vibrio fischeri | Model for synergistic protein-RNA interactions at promoters |
| RNA polymerase | Binds promoter region RNA and DNA to initiate transcription | Core component of transcription machinery with RNA-binding capability |
| TNF-alpha | Cytokine mRNA with a 3' UTR regulatory region bound by RBPs | Inflammatory disease and mRNA stability regulation |
| IL-3 | Cytokine gene with a 3' regulatory region bound by proteins | Hematopoietic malignancies and autocrine transformation |
| BHV-4 IE2 | Viral transactivator that binds a promoter-regulatory region of a late RNA | Viral pathogenesis and late gene regulation |
| Various RBPs | Recognize high-confidence RNA regulatory elements | Identification of RNA regulatory networks |
| RNA-binding proteins (general) | Form complexes with regulatory RNAs | Biochemical and genomic probing of RNA-protein networks |
| G-quadruplex-binding proteins | Bind G-quadruplex structures in regulatory RNAs | Transposable element regulation and genome stability |
| RNA localization factors | Bind regulatory RNAs to control localization | RNA localization pathways and disease |
| Splicing factors | Bind regulatory regions to modulate splicing | Gene expression regulation |
| Poly(A)-binding proteins | Bind 3' UTR regulatory elements | mRNA stability and translation |
| Translation initiation factors | Bind regulatory regions to control translation | Protein synthesis regulation |
| DNA repair proteins | Bind RNA regions that regulate DNA repair | Genome stability |
| Replication proteins | Bind RNA regions that regulate DNA replication | Cell cycle control |
| Transcription factors | Bind promoter-associated RNAs | Transcriptional regulation |
| Viral transactivators | Bind viral promoter-regulatory RNAs | Viral gene expression |
| Cytokine mRNA-binding proteins | Bind 3' UTRs of cytokine mRNAs | Inflammation and hematopoiesis |
How Is regulatory region RNA binding Regulated?
Regulatory region RNA binding is itself regulated at multiple levels. The availability of specific RNA regions can be controlled by transcription, RNA processing, and RNA stability. Post-translational modifications of RNA-binding proteins, such as phosphorylation, can alter their affinity for regulatory RNAs. In addition, the formation of RNA secondary structures, including G-quadruplexes, can modulate protein binding to regulatory regions. Combinatorial classification of RNA-protein binding sites has revealed that high-confidence regulatory elements are often bound by multiple proteins in a context-dependent manner, suggesting a complex regulatory network. Viral proteins can also regulate this activity, as seen with the BHV-4 IE2 transactivator binding to a promoter-regulatory region.
regulatory region RNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL-3 | Hematological malignancies, autocrine transformation | Knockout of IL-3 3' regulatory region binding proteins in hematopoietic cell lines |
| TNF-alpha | Inflammatory diseases | Point mutation of the 3' UTR regulatory region in macrophage cell lines |
| BHV-4 IE2 | Viral pathogenesis | Knock-in of IE2 binding site mutations in viral genomes |
| DNA repair proteins | Genome instability, cancer | Knockout of RNA-binding domains in DNA repair proteins |
| RNA-binding proteins (general) | Various cancers and neurological disorders | Overexpression or knockout in disease-relevant cell models |
Regulatory region RNA binding in hematological malignancies
Dysregulated regulatory region RNA binding has been implicated in hematological malignancies. Proteins binding the 3' regulatory region of the IL-3 gene show altered complex formation in IL-3-dependent and autocrine-transformed hematopoietic cells, suggesting a role in leukemogenesis. These findings indicate that aberrant RNA-protein interactions at cytokine gene regulatory regions can contribute to uncontrolled cell growth and survival.
Inflammatory diseases and cytokine regulation
The TNF-alpha 3' UTR contains a regulatory region that binds specific RNA-binding proteins, and these interactions are thought to control TNF-alpha mRNA stability and translation. Dysregulation of such binding can lead to excessive or insufficient cytokine production, contributing to inflammatory diseases. Thus, regulatory region RNA binding is a potential therapeutic target for modulating inflammation.
Viral pathogenesis and gene regulation
Viruses exploit regulatory region RNA binding to control their gene expression. Bovine herpesvirus 4 encodes an abundant late RNA with a promoter-regulatory region that binds the viral IE2 transactivator, highlighting how RNA-protein interactions at regulatory regions are critical for viral replication and pathogenesis. Similar mechanisms may operate in other viruses, making this function relevant to antiviral research.
Genome stability and DNA repair
Regulatory region RNA binding also plays a role in DNA repair and genome stability. RNA regions that regulate DNA repair processes can be bound by specific proteins, and disruption of these interactions may lead to genomic instability. This links regulatory region RNA binding to cancer predisposition and aging.
From regulatory region RNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a specific RNA-binding protein regulate transcription via promoter RNA binding? | Knockout cell line for the RNA-binding protein |
| Does a point mutation in a regulatory RNA region abolish protein binding? | Point mutation knock-in cell line |
| Can a tagged RNA-binding protein be used to map binding sites? | Tagged knock-in of the RNA-binding protein |
| Does overexpression of an RNA-binding protein alter disease phenotype? | Overexpression cell model |
| Is a regulatory RNA region necessary for viral replication? | Knockout of the regulatory region in a viral genome |
| Can CRISPR library screening identify novel regulators of regulatory region RNA binding? | CRISPR library screening in relevant cell lines |
How to Study the regulatory region RNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RIP-seq | RNA regions bound by a protein of interest | Mapping regulatory region RNA binding sites |
| CLIP-seq | Direct protein-RNA interactions at nucleotide resolution | Identifying high-confidence RNA regulatory elements |
| EMSA | In vitro binding affinity and specificity | Validating direct binding to regulatory RNA regions |
| RNA pull-down | Proteins associated with a specific RNA region | Discovering novel RNA-binding proteins |
| CRISPR knockout | Loss-of-function effects on regulatory region RNA binding | Testing causal roles in gene expression |
| CRISPR point mutation | Effect of specific nucleotide changes on RNA binding | Dissecting regulatory element function |
| CRISPR knock-in | Tagged or mutant protein expression | Mapping binding sites in vivo |
| CRISPR overexpression | Gain-of-function effects | Modeling disease-associated overexpression |
RNA immunoprecipitation and CLIP-seq
RNA immunoprecipitation (RIP) and crosslinking and immunoprecipitation followed by sequencing (CLIP-seq) are key methods to identify RNA regions bound by specific proteins. These techniques enable mapping of regulatory region RNA binding sites across the transcriptome and can reveal high-confidence RNA regulatory elements when combined with computational classification.
Combinatorial classification of RNA-protein binding sites
Combinatorial classification integrates multiple RNA-protein binding datasets to distinguish functional, high-confidence regulatory elements from background binding. This approach is essential for identifying bona fide regulatory region RNA binding events and for prioritizing candidates for functional studies.
Biochemical probing of RNA-protein networks
Biochemical methods, such as electrophoretic mobility shift assays (EMSAs) and RNA pull-down, can probe direct interactions between proteins and regulatory RNA regions. These techniques provide quantitative measures of binding affinity and specificity, and they complement genomic approaches.
CRISPR-based functional assays
CRISPR-Cas9 genome editing enables knockout, point mutation, knock-in, and overexpression of genes encoding RNA-binding proteins or regulatory RNA regions. These models allow causal testing of whether a specific regulatory region RNA binding event is required for a biological process or disease phenotype.
How CRISPR Can Be Used to Study GO:0001069 regulatory region RNA binding
Knockout
CRISPR knockout of genes encoding RNA-binding proteins or regulatory RNA regions can abolish regulatory region RNA binding and reveal its contribution to transcription, DNA replication, or DNA repair. For example, knocking out proteins that bind the IL-3 3' regulatory region can test their role in hematopoietic transformation.
Point Mutation
CRISPR point mutation can introduce precise nucleotide changes in regulatory RNA regions to disrupt or enhance protein binding. This approach is useful for defining the minimal sequence elements required for high-confidence RNA regulatory element function.
Knock-in
CRISPR knock-in can insert tags or reporter sequences into endogenous loci to track RNA-binding protein localization and interactions. Tagged knock-in models enable CLIP-seq and imaging studies of regulatory region RNA binding in a physiological context.
Overexpression
CRISPR overexpression (e.g., via CRISPR activation) can elevate levels of RNA-binding proteins to model gain-of-function states observed in disease. Overexpression models are particularly useful for studying oncogenic roles of regulatory region RNA binding in leukemia and solid tumors.
How EDITGENE Supports regulatory region RNA binding Research
Researchers studying regulatory region RNA binding-related genes often need to determine whether a candidate gene is causally involved in a specific nucleic acid-based process or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from knockout and point mutation to knock-in, overexpression, and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulatory region RNA binding research.
Frequently Asked Questions About regulatory region RNA binding
What is GO:0001069 regulatory region RNA binding?
GO:0001069 is a molecular function defined as binding to an RNA region that regulates a nucleic acid-based process, such as transcription, DNA replication, or DNA repair.
What genes are involved in regulatory region RNA binding?
Genes encoding RNA-binding proteins, transcription factors, and viral transactivators, such as LuxR, TNF-alpha, IL-3, and BHV-4 IE2, are involved in regulatory region RNA binding.
How is regulatory region RNA binding studied?
It is studied using RNA immunoprecipitation, CLIP-seq, combinatorial classification of RNA-protein binding sites, and CRISPR-based functional assays.
What diseases are associated with regulatory region RNA binding?
Diseases include hematological malignancies, inflammatory diseases, viral pathogenesis, and genome instability disorders.
What is the difference between regulatory region RNA binding and general RNA binding?
Regulatory region RNA binding specifically refers to binding RNA regions that regulate nucleic acid-based processes, whereas general RNA binding can occur anywhere on an RNA molecule.
Which proteins bind the TNF-alpha 3' regulatory region?
Specific RNA-binding proteins form complexes with a novel putative regulatory region in the 3' UTR of TNF-alpha mRNA.
How does regulatory region RNA binding affect transcription?
It can modulate RNA polymerase recruitment and activity, as shown by the synergistic binding of LuxR and RNA polymerase to the lux promoter region.
Can CRISPR be used to study regulatory region RNA binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of regulatory region RNA binding.
What is the role of regulatory region RNA binding in leukemia?
Proteins binding the 3' regulatory region of the IL-3 gene show altered complex formation in autocrine-transformed hematopoietic cells, suggesting a role in leukemogenesis.
How can I identify high-confidence RNA regulatory elements?
Combinatorial classification of RNA-protein binding sites from multiple datasets can identify high-confidence RNA regulatory elements.
Conclusion
GO:0001069 regulatory region RNA binding is a fundamental molecular function that connects RNA recognition to the control of transcription, DNA replication, and DNA repair. Its roles in gene regulation, viral pathogenesis, and human disease make it a compelling area of research. By combining biochemical, genomic, and CRISPR-based approaches, researchers can dissect the mechanisms and causal contributions of regulatory region RNA binding in health and disease. EDITGENE provides the tools and services needed to accelerate these discoveries.
References
- 1. Bovaird S et al.. 2018. Biological functions, regulatory mechanisms, and disease relevance of RNA localization pathways.. FEBS Lett 592(17):2948-2972 PMID: 30132838
- 2. Li YE et al.. 2017. Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA-protein binding sites.. Genome Biol 18(1):169 PMID: 28886744
- 3. Campbell ZT et al.. 2015. Probing RNA-protein networks: biochemistry meets genomics.. Trends Biochem Sci 40(3):157-64 PMID: 25636997
- 4. Kejnovsky E et al.. 2015. Transposable elements and G-quadruplexes.. Chromosome Res 23(3):615-23 PMID: 26403244
- 5. Bermudez-Cruz R et al.. 1997. Characterization of an abundant, unique 1.7-kilobase bovine herpesvirus 4 (BHV-4) late RNA and mapping of a BHV-4 IE2 transactivator-binding site in its promoter-regulatory region.. J Virol 71(1):527-38 PMID: 8985381
- 6. Stevens AM et al.. 1994. Synergistic binding of the Vibrio fischeri LuxR transcriptional activator domain and RNA polymerase to the lux promoter region.. Proc Natl Acad Sci U S A 91(26):12619-23 PMID: 7809088
- 7. Hel Z et al.. 1998. Characterization of the RNA binding proteins forming complexes with a novel putative regulatory region in the 3'-UTR of TNF-alpha mRNA.. Nucleic Acids Res 26(11):2803-12 PMID: 9592171
- 8. Wang XY et al.. 1998. Characterization of proteins binding the 3' regulatory region of the IL-3 gene in IL-3-dependent and autocrine-transformed hematopoietic cells.. Leukemia 12(4):520-31 PMID: 9557611
